Related references
Note: Only part of the references are listed.Modern Approaches to Treating Acute Promyelocytic Leukemia
Miguel A. Sanz et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
Francesco Lo-Coco et al.
BLOOD (2010)
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
Stephan A. Mayer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review
M. Franchini et al.
BONE MARROW TRANSPLANTATION (2007)
Use of NovoSeven (R) for arsenic trioxide-induced bleeding in PML
Kamran Alimoghaddam et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia
S Zver et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Share Paper
